Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FLYWCH-type zinc finger-containing protein 1 (FLYWCH1) is a nuclear transcription factor belonging to the Cys2-His2 (C2H2)-type zinc finger protein family, containing a tandem array of five FLYWCH-type zinc finger motifs and a nuclear localization signal[1][4]. It is mainly localized in the nuclear bodies and nucleoplasm, and is involved in regulating the DNA damage response, specifically by modulating H2AX phosphorylation independently of ATM, implicating a novel signaling axis in DNA repair processes[1]. FLYWCH1 affects key cell behaviors, such as proliferation, migration, and attachment, and shows altered expression under DNA damage stress and anticancer drug exposure (e.g., cisplatin)[1]. While FLYWCH1 itself is not directly targeted by drugs nor considered a canonical therapeutic receptor or enzyme, it may modulate sensitivity to DNA-damaging agents and is under investigation for its regulatory role in cancer biology[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FLYWCH-type zinc finger-containing protein 1 (FLYWCH1).